Marshall Wace’s Instil Bio TIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44,878
Closed -$802K 3478
2025
Q3
$802K Buy
+44,878
New +$1.14M ﹤0.01% 2037
2025
Q2
Sell
-22,298
Closed -$387K 3173
2025
Q1
$387K Sell
22,298
-1,400
-6% -$29K ﹤0.01% 2177
2024
Q4
$452K Buy
23,698
+272
+1% +$8.29K ﹤0.01% 2076
2024
Q3
$1.58M Sell
23,426
-37,200
-61% -$876K ﹤0.01% 1457
2024
Q2
$624K Hold
60,626
﹤0.01% 1883
2024
Q1
$655K Hold
60,626
﹤0.01% 1826
2023
Q4
$462K Hold
60,626
﹤0.01% 1744
2023
Q3
$521K Sell
60,626
-20,167
-25% -$203K ﹤0.01% 1710
2023
Q2
$889K Hold
80,793
﹤0.01% 1768
2023
Q1
$1.07M Hold
80,793
﹤0.01% 1773
2022
Q4
$1.02M Hold
80,793
﹤0.01% 2086
2022
Q3
$7.82M Hold
80,793
0.02% 1071
2022
Q2
$7.46M Buy
80,793
+11,172
+16% +$1.58M 0.02% 1069
2022
Q1
$15M Hold
69,621
0.03% 615
2021
Q4
$23.8M Buy
69,621
+60,626
+674% +$23.4M 0.04% 431
2021
Q3
$3.22M Hold
8,995
0.01% 1218
2021
Q2
$3.48M Hold
8,995
0.02% 1049
2021
Q1
$4.51M Buy
+8,995
New +$4.62M 0.02% 897

Other funds holding TIL

Marshall Wace's TIL Position: Q4 2025 in Review

Marshall Wace sold out of Instil Bio (TIL) in Q4 2025, closing a stake of 44,878 shares — an estimated $802K sold.

Marshall Wace first reported a position in TIL in Q1 2021 and held it in 18 quarters. The position peaked at $23.8M in Q4 2021. 29 funds tracked by Wall St. Rank hold TIL as of Q4 2025.

  • Marshall Wace reported no remaining Instil Bio position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 44,878 Instil Bio shares in Q4 2025, an estimated $802K.
  • Marshall Wace first reported a position in Instil Bio in Q1 2021 and held it in 18 quarters.
  • Marshall Wace's Instil Bio position peaked at $23.8M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Instil Bio as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.